These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35644502)

  • 1. Single Versus Dual Antiplatelet Therapy following Left Atrial Appendage Occlusion in Patients With High Bleeding Risk.
    Mhanna M; Beran A; Al-Abdouh A; Jabri A; Al-Aaraj A; Sajdeya O; Abuhelwa Z; Khokher W; Bhuta S; Burmeister CJ; Eltahawy EA
    Curr Probl Cardiol; 2022 Sep; 47(9):101269. PubMed ID: 35644502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Single Versus Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion.
    Patti G; Sticchi A; Verolino G; Pasceri V; Vizzi V; Brscic E; Casu G; Golino P; Russo V; Rapacciuolo A; Boccuzzi G; Mangieri A; Pagnotta PA; Colombo A;
    Am J Cardiol; 2020 Nov; 134():83-90. PubMed ID: 32892987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Looking for optimal antithrombotic strategy after transcatheter left atrial appendage occlusion: a real-world comparison of different antiplatelet regimens.
    Vignali L; Gurgoglione FL; Barocelli F; Cattabiani MA; Solinas E; Maini A; Tadonio I; Benatti G; Pelà G; Coli S; Ardissino D; Niccoli G
    Int J Cardiol; 2023 Jan; 371():92-99. PubMed ID: 36181948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single versus dual antiplatelet therapy following percutaneous left atrial appendage closure-A systematic review and meta-analysis.
    Continisio S; Montonati C; Angelini F; Bocchino PP; Carbonaro C; Giacobbe F; Dusi V; De Filippo O; Ielasi A; Giannino G; Boldi E; Fabris T; D'Ascenzo F; De Ferrari GM; Tarantini G
    Eur J Clin Invest; 2024 Aug; 54(8):e14209. PubMed ID: 38597271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network Meta-Analysis of Initial Antithrombotic Regimens After Left Atrial Appendage Occlusion.
    Carvalho PEP; Gewehr DM; Miyawaki IA; Nogueira A; Felix N; Garot P; Darmon A; Mazzone P; Preda A; Nascimento BR; Kubrusly LF; Cardoso R
    J Am Coll Cardiol; 2023 Oct; 82(18):1765-1773. PubMed ID: 37611779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term direct oral anticoagulation or dual antiplatelet therapy following left atrial appendage closure in patients with relative contraindications to chronic anticoagulation therapy.
    Faroux L; Cruz-González I; Arzamendi D; Freixa X; Nombela-Franco L; Peral V; Caneiro-Queija B; Mangieri A; Trejo-Velasco B; Asmarats L; Regueiro A; McInerney A; Mas-Lladó C; Estevez-Loureiro R; Laricchia A; O'Hara G; Rodés-Cabau J
    Int J Cardiol; 2021 Jun; 333():77-82. PubMed ID: 33647365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: the PLATEBRISK study.
    Antúnez-Muiños P; López-Tejero S; Cepas-Guillén P; Mon-Noboa M; Ruiz-Nodar JM; Andrés-Lalaguna L; Rivero F; Córdoba-Soriano JG; Amat-Santos IJ; Caneiro-Queija B; Sánchez DM; Sánchez JJ; Mezcua FT; Blanco-Fernández F; Sánchez JS; Moreno-Ambroj C; Estévez-Loureiro R; Nombela-Franco L; Freixa-Rofastes X; Cruz-González I
    EuroIntervention; 2024 Aug; 20(16):1018-1028. PubMed ID: 39155755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual antiplatelet therapy after percutaneous left atrial appendage occlusion: single center experience with the Amplatzer Cardiac Plug.
    Bertrand PB; Habran M; Kenis K; Lecomte J; Moonen L; Stroobants D; Benit E
    Acta Cardiol; 2019 Feb; 74(1):74-81. PubMed ID: 29607737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of catheter-based left atrial appendage closure in patients with contraindications for long-term anticoagulation.
    Seidel A; Parwani AS; Krackhardt F; Huemer M; Attanasio P; Haverkamp W; Pieske B; Boldt LH
    Minerva Cardioangiol; 2017 Dec; 65(6):545-552. PubMed ID: 28565887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies.
    Bavishi C; Koulova A; Bangalore S; Sawant A; Chatterjee S; Ather S; Valencia J; Sarafoff N; Rubboli A; Airaksinen JK; Lip GY; Tamis-Holland JE
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):E12-22. PubMed ID: 26354765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual antiplatelet therapy is safe and efficient after left atrial appendage closure.
    Maksym J; Mazurek T; Kochman J; Grygier M; Kapłon-Cieślicka A; Marchel M; Lodziński P; Piątkowski R; Wilimski R; Czub P; Fojt A; Karolczak N; Hendzel P; Opolski G
    Kardiol Pol; 2018; 76(2):459-463. PubMed ID: 29350390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic Regimen After Percutaneous Left Atrial Appendage Closure　- A Real-World Study.
    Ryuzaki S; Kondo Y; Nakano M; Nakano M; Kajiyama T; Ito R; Kitagawa M; Sugawara M; Chiba T; Yoshino Y; Kobayashi Y
    Circ J; 2023 Nov; 87(12):1820-1827. PubMed ID: 37344404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
    Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW;
    Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial appendage occlusion for atrial fibrillation and bleeding diathesis.
    Kailey BS; Koa-Wing M; Sutaria N; Mott T; Sohaib A; Qureshi N; Shi C; Padam P; Howard J; Kanagaratnam P
    J Cardiovasc Electrophysiol; 2023 Dec; 34(12):2552-2562. PubMed ID: 37962263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.
    Grosset-Janin D; Barth E; Bertrand B; Detante O
    Rev Neurol (Paris); 2015 May; 171(5):426-32. PubMed ID: 25912470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of a randomized clinical trial to compare two antithrombotic strategies after left atrial appendage occlusion: double antiplatelet therapy vs. apixaban (ADALA study).
    Flores-Umanzor EJ; Cepas-Guillen PL; Arzamendi D; Cruz-González I; Regueiro A; Freixa X
    J Interv Card Electrophysiol; 2020 Nov; 59(2):471-477. PubMed ID: 32986176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial and long-term antithrombotic therapy after left atrial appendage closure with the WATCHMAN.
    Ledwoch J; Sievert K; Boersma LVA; Bergmann MW; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts TR; Mazzone P; Foley D; Grygier M; De Potter T; Sievert H;
    Europace; 2020 Jul; 22(7):1036-1043. PubMed ID: 32464648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices.
    Weise FK; Bordignon S; Perrotta L; Konstantinou A; Bologna F; Nagase T; Chen S; Chun KRJ; Schmidt B
    EuroIntervention; 2018 Apr; 13(18):e2138-e2146. PubMed ID: 29400653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.